Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas — Stella

Home/Bone Sarcomas/

View on ClinicalTrials.gov

Recruiting

Back to Bone Sarcomas trials

Trial locations(1 site)

United States

MD Anderson Cancer Center, Houston, Texas

Key details

Sponsor

M.D. Anderson Cancer Center

Enrollment target

~100 participants

Started

September 2025

Primary completion

October 2028

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.